These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 20837588

  • 1. Open-label glucocorticoids modulate dexamethasone trial results in preterm infants.
    Onland W, van Kaam AH, De Jaegere AP, Offringa M.
    Pediatrics; 2010 Oct; 126(4):e954-64. PubMed ID: 20837588
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial.
    Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB, DART Study Investigators.
    Pediatrics; 2006 Jan; 117(1):75-83. PubMed ID: 16396863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
    Cummings JJ, D'Eugenio DB, Gross SJ.
    N Engl J Med; 1989 Jun 08; 320(23):1505-10. PubMed ID: 2657423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C, Bowling S, Williamson K, McGaw P, Durand M.
    Pediatr Pulmonol; 2004 Jul 08; 38(1):55-63. PubMed ID: 15170874
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
    Watterberg KL, American Academy of Pediatrics. Committee on Fetus and Newborn.
    Pediatrics; 2010 Oct 08; 126(4):800-8. PubMed ID: 20819899
    [Abstract] [Full Text] [Related]

  • 13. [Bronchopulmonary dysplasia. Retrospective analysis of various forms of treatment and development of a staged therapeutic plan].
    Bauer J, Beedgen B, Böhler T, Sontheimer D, Zilow EP, Linderkamp O.
    Klin Padiatr; 1996 Oct 08; 208(2):56-60. PubMed ID: 8901183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.
    Onland W, Offringa M, Cools F, De Jaegere AP, Rademaker K, Blom H, Cavatorta E, Debeer A, Dijk PH, van Heijst AF, Kramer BW, Kroon AA, Mohns T, van Straaten HL, te Pas AB, Theyskens C, van Weissenbruch MM, van Kaam AH.
    BMC Pediatr; 2011 Nov 09; 11():102. PubMed ID: 22070744
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.